Metabolomic Variations in the Saxagliptin-Treated Type 2 Diabetes Mellitus Patients
Status:
Unknown status
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
This study is an open-label, cohort study to evaluate the potential mechanisms of Saxagliptin
in the treatment of patients with type 2 diabetes (T2DM) using a comprehensive metabolomic
method, in combination with fingerprint analysis and target analysis. It is a sub-study of
STUDY: D168L00008.